ASPEN PHARMACARE HOLDINGS LIMITED - Further announcement regarding the divestment of a portfolio of branded and generic products to Strides entities

Further announcement regarding the divestment of a portfolio of branded and generic products to Strides entities

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
(“Aspen Holdings”)



FURTHER ANNOUNCEMENT REGARDING THE DIVESTMENT OF A PORTFOLIO OF BRANDED AND GENERIC
PRODUCTS TO STRIDES ENTITIES - CONDITIONS PRECEDENT FULFILLED

Shareholders are referred to the announcement released by Aspen Holdings on 21 May 2015 wherein it
was confirmed, inter alia, that certain of its wholly owned Australian subsidiaries (collectively “Aspen
Australia”), had entered into an agreement with Strides (Australia) Pharma Pty Ltd (“Strides Australia”), a
company incorporated in Australia, in terms whereof Aspen Australia would divest to Strides Australia, a
portfolio of approximately 130 products.

It was also announced that Aspen Global Incorporated (“AGI”), a wholly owned subsidiary of Aspen
Holdings incorporated in Mauritius, had entered into a separate transaction to divest of a portfolio of six
branded prescription products to Strides Pharma Global Pte Limited (“Strides Singapore”), a company
incorporated in Singapore.

Aspen is pleased to confirm that all the contractual conditions precedent in respect of both these
transactions were satisfied on 1 August 2015 and that these transactions are expected to complete on 31
August 2015.


Durban
11 August 2015

Sponsor:
Investec Bank Limited

Date: 11/08/2015 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.